An overview of the Indian Pharmaceutical industry

The Indian pharmaceutical industry has emerged as the third largest country in the world in terms of volume with a turnover amounting to US $ 21.04 billion in 2009. In addition to this, the industry includes more than 20,000 licensed companies that employs 500,000 people (Industry, 2011). Furthermore, Indian pharmaceutical industry secured the top position among the science based industries through a range of capabilities in production and technology. In terms of market segmentation, leading 250 pharmaceutical companies have controlled 70 % of the market (PwC, 2012).

Exports from the Indian Pharmaceutical industry

The Indian pharmaceutical industry has acquired the position of largest exporter among the developing countries. The export market is driven by price, quality and safety of the products. The Indian exports in the pharmaceutical industry have grown from US$ 7.24 billion in 2007 to US $ 9.35 billion in 2009 (Price Waterhouse Coopers PwC, 2010). These exports are destined to various countries across the world including USA, Europe, Japan and Australia. The exports of pharmaceuticals have shown immense growth displaying a compound annual growth rate of 17.8% during the period 2003-04. In terms of composition of exports, share of basic drugs was 43%, fine chemicals and intermediates captured 55% of share and 2% of herbals were exported from India (McKinsey, 2014). In terms of imports, China has accounted for India’s 66 % pharmaceutical imports (Price Waterhouse Coopers PwC, 2010).

Growth drivers of the Indian pharmaceutical industry

Prior to the introduction of patents act of 1970, multinational companies dominated the Indian market. But, soon after the patents act, Indian companies started to enter the market and delivered expertise in the production of drugs at a very low cost (FICCI, 2018). The industry has displayed a high rate of growth through improved technology, range and the quality of products manufactured. In addition to this, demand drivers include the growing and ageing global population. The rise in the infectious diseases has demanded greater access to healthcare services. Furthermore, affordable health care services have offered new opportunities for growth of the industry (Tewathia, 2014).

The change in the favorable demographics, socio economic changes, urbanisation has led to rapid transition. The demand is  driven by active participation of pharmaceutical chemicals. Furthermore, many multinational companies have captured the Indian market through acquisitions and launch of new products. Lastly, many multinational companies have also followed a differential price strategy to strengthen their presence in India through availability and affordability of products (McKinsey, 2014).

Future of the Indian Pharmaceutical industry

However, the growth in the pharmaceutical industry is hindered by some challenges. The business of pharmaceuticals due to rise in the drug discovery cost. In addition to this, the government intervention in the form of hasher price controls and taxes has created a pressure on the market. The government has laid down tight rules governing the development and production of medicines. Furthermore, over the past few years, the annual output of pharma industry has flat lined.

The future of the pharmaceutical industry will be driven by profitability and operational excellence. The manufactures will be competing in terms of ground and increase in complexity, additional controls and market disruptions in the global supply. The industry needs to generate efficiency to drive the market by achieving cost efficiency. The future trend will be driven by companies specialising in differentiated products which will require reinventing the operative model  and pursuing a systematic investment strategy.


Divya Narang

Divya Narang

Research analyst at Project Guru
Divya is a Masters in economics with a specialization in econometrics. She has worked on various research works in the field of economics and finance. Apart from this, she has developed keen interest in business management, business policy, international marketing and strategic management. Her methodological work focuses on analysis on panel data using statistical software like SPSS and STATA. She loves to spend her spare time reading novels and playing badminton.
Divya Narang

Related articles

  • An overview of the pharmaceutical industry of India The pharmaceutical industry of India consists of the total value of pharmaceutical formulations sold in India. It is one of the major contributors in the healthcare industry. Indian pharmaceutical also plays a major role in the contribution of drugs globally. It provides many vaccines, […]
  • An overview of the growing chemical industry in India The Indian chemical industry has gained a major share in Asia’s growing contribution to the global chemical industry. It has also emerged as one of the preferred destinations for investment in the chemical industry worldwide (Chambers, Road, & Nadu, 2012).
  • An overview of the Indian textile industry The Indian textile industry has occupied a prominent place in the economic development of the country since independence. The industry has expanded at a very fast rate to become the second largest producer of textile and garments.
  • Impact of FDI inflows on the exports of India The aim of this article is to investigate the impact of FDI inflows on the exports of India. The relationship between FDI and exports has been of great interest to researchers especially after the economic liberalisation in 1991.
  • Drawbacks and benefits of increasing FDI in retail in India FDI or foreign direct investment is the investments brought into productions and economy of a country by people of another country. USA was the world's largest recipient of FDI totaling $194 billion in 2010 after which in line was China with $185 billion in 2010 and India in 2010 was […]


We are looking for candidates who have completed their master's degree or Ph.D. Click here to know more about our vacancies.